How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Buy
61
BMRN Quote, Financials, Valuation and Earnings
Last price:
$70.69
Seasonality move
:
2.18%
Day range:
$69.05 - $71.28
52-week range:
$60.63 - $94.85
Dividend yield:
0%
P/E ratio:
32.13x
P/S ratio:
4.91x
P/B ratio:
2.38x
Volume:
1.6M
Avg. volume:
1.6M
1-year change:
-19.06%
Market cap:
$13.5B
Revenue:
$2.9B
EPS (TTM):
$2.20
BMRN Analysts' Consensus Rating
The 22 analysts providing 12-month price projections for Biomarin Pharmaceutical shares anticipate an average target of $96.72, ranging from a low estimate of $65.00 to a high estimate of $126.00. This average target implies a growth of 36.83% compared to the current stock price of $70.69.
Consensus Price Target
$96.72
Highest Price Target
$126.00
Lowest Price Target
$65.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 14 | 16 | 16 |
| Hold | 6 | 6 | 6 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
BMRN Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
69
AJINY alert for Apr 1
Ajinomoto [AJINY] is down 2.15% over the past day.
Sell
40
RGC alert for Mar 31
Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.
Buy
62
AGX alert for Apr 1
Argan [AGX] is down 4.98% over the past day.
